All In MedTech

Device type · JGS

Electrode, Ion Specific, Sodium

FDA groups similar devices under a three-letter product code. This page gathers what FDA's public data says about JGS: how it is classified, what has been cleared or approved, and what has been reported and recalled.

Last checked: Nov 19, 2026Source: openFDAMethods & limitations

Product code

JGS

Clinical Chemistry

Device class

Class II

FDA decisions since 2015

19

510(k), De Novo and PMA

Adverse event reports

110

Received Nov 1, 2025 to Nov 20, 2026

How FDA classifies it

Device type
Electrode, Ion Specific, Sodium
Product code
JGS
Device class
Class II
Review panel
Clinical Chemistry
Regulation
21 CFR 862.1665

Latest FDA decisions

The 8 newest of 19 since 2015.

All decisions for JGS

16 more FDA decisions with a free account

Reports received

110

Received Nov 1, 2025 to Nov 20, 2026

Malfunction reports

110

100% of reports

Injury reports

0

0.0% of reports

Death reports

0

0.0% of reports

Adverse event reports received per month

By the date FDA received each report, stacked by event type. The newest month is incomplete.

Open in the MAUDE Monitor
  • Malfunction
  • Injury
  • Death
  • Other
View as table
MonthMalfunctionInjuryDeathOther
Dec 2312000
Jan 245000
Feb 2410000
Mar 2418000
Apr 2411000
May 2410000
Jun 243000
Jul 2410000
Aug 247000
Sep 244000
Oct 245000
Nov 246000
Dec 247000
Jan 254000
Feb 2510000
Mar 252000
Apr 255000
May 255000
Jun 251000
Jul 255000
Aug 254000
Sep 2510000
Oct 254000
Nov 257000
Dec 258000
Jan 263000
Feb 263000
Mar 269000
Apr 269000
May 267000
Jun 2625000
Jul 2626000
Aug 263000
Sep 264000
Oct 266000
Nov 260000

Manufacturers named most often

Last 12 months. Bigger sellers get more reports. This is not a ranking of safety.

3 more in this ranking with a free account

Device problems as coded

Last 12 months. FDA's terms. A report can carry several.

  • High Test Results73
  • Low Test Results20
  • Non Reproducible Results20

5 more in this ranking with a free account

Patient problems as coded

Last 12 months. FDA's terms. A report can carry several.

  • No Clinical Signs, Symptoms or Conditions104
  • Facial Paralysis2
  • Hyperkalemia2

5 more in this ranking with a free account

Recent recalls

From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.

  • Siemens Healthcare Diagnostics Inc

    Z-2272-2025 · Started Jul 7, 2025 · Posted by FDA Aug 5, 2025

    Reason given: Siemens Healthcare Diagnostics Inc. has confirmed that a negative sodium bias may exist in some epoc test card lots. All other analytes are performing as intended. The observed average bias for sodium was -4.4 mmol/L. The maximum bias observed was -14 mmol/L, which occurred at a higher sodium concentration around 150...

    Cause as FDA categorized it: Under Investigation by firm

  • Siemens Healthcare Diagnostics Inc

    Z-0422-2024 · Started Sep 26, 2023 · Posted by FDA Dec 1, 2023

    Reason given: There are potential drug interferences from Perhexiline Maleate or Atomoxetine Hydrochloride that may cause falsely elevated sodium results reported on the RAPIDPoint 500 and RAPIDPoint 500e Blood Gas Systems. The erroneous sodium levels with positive bias may lead to unrecognized hyponatremia and/or the inappropriate...

    Cause as FDA categorized it: Under Investigation by firm

  • Siemens Healthcare Diagnostics Inc

    Z-0423-2024 · Started Sep 26, 2023 · Posted by FDA Dec 1, 2023

    Reason given: There are potential drug interferences from Perhexiline Maleate or Atomoxetine Hydrochloride that may cause falsely elevated sodium results reported on the RAPIDPoint 500 and RAPIDPoint 500e Blood Gas Systems. The erroneous sodium levels with positive bias may lead to unrecognized hyponatremia and/or the inappropriate...

    Cause as FDA categorized it: Under Investigation by firm

45 more recall records with a free account

Back to all tools

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.